Cabergoline: a long-acting dopamine agonist in Parkinson's disease.
Lera
G
G
Vaamonde
J
J
Muruzabal
J
J
Obeso
J A
JA
D000284:Administration, Oral; D000978:Antiparkinson Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000077465:Cabergoline; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects
D000978:Antiparkinson Agents; D004873:Ergolines; D011954:Receptors, Dopamine; D007980:Levodopa; D000077465:Cabergoline